Skip to main content
GutCited

Lactobacillus plantarum لـ Irritable Bowel Syndrome (IBS)

B

Reduces abdominal pain and bloating in IBS. Multiple RCTs show significant improvement in global IBS symptom scores. Strain-specific evidence for 299v is relatively strong.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dlactobacillus\u002Dplantarum\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

الخلاصة

Reduces abdominal pain and bloating in IBS. Multiple RCTs show significant improvement in global IBS symptom scores. Strain-specific evidence for 299v is relatively strong.

Key Study Findings

Meta-Analysis n=3154
Comparative effectiveness and safety of probiotics with psychotropic potential in mental health benefits in irritable …
Dose: None مقابل: placebo Outcome: quality of life, depression, and anxiety in IBS … التأثير: SUCRA=89.7% (B. longum for QoL); SUCRA=95.6% (probiotic combo for depression) None

المجتمع المدروس: patients with irritable bowel syndrome

Meta-Analysis
Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome.
Dose: None مقابل: placebo Outcome: improvement in key IBS symptoms التأثير: None None

المجتمع المدروس: patients with IBS from 32 RCTs evaluating 10 probiotic strains

Other n=25 4 weeks
Effect of probiotic administration of Bifidobacterium animalis subsp. lactis BB-12 and Lactiplantibacillus plantarum ATCC 14917 …
Dose: Bifidobacterium animalis subsp. lactis BB-12 and Lactiplantibacillus plantarum ATCC 14917 مقابل: phosphate-buffered saline (PBS) Outcome: visceral hypersensitivity (abdominal withdrawal reflex scores) التأثير: None p<0.05

المجتمع المدروس: female rats with water avoidance stress-induced IBS-D model

Other n=1098 8 weeks Open-label
A multicenter real-world, open-label study assessing the impact of a probiotic mixture on symptoms of …
Dose: None مقابل: None (single-arm open-label) Outcome: Treatment success for abdominal pain and bloating التأثير: 73% pain, 81.9% bloating success at T1 <0.001

المجتمع المدروس: IBS patients from 52 Italian gastroenterologists

Other
Lactobacillus plantarum and Galacto-Oligosaccharides Synbiotic Relieve Irritable Bowel Syndrome by Reshaping Gut Microbiota and Attenuating …
Dose: 1e9 CFU/day + GOS 10 g/L مقابل: IBS model mice without synbiotic Outcome: IBS symptoms and colonic dysfunction التأثير: None <0.05

المجتمع المدروس: C. rodentium + WAS IBS mouse model

Randomized Controlled Trial n=61 12 weeks Double-blind
Four-strain probiotic exerts a positive effect on irritable bowel syndrome symptoms occurring in inflammatory bowel …
Dose: None مقابل: Placebo Outcome: IBS-SSS (100-point reduction) التأثير: 45% active vs 33% placebo (P=0.42) P=0.42

المجتمع المدروس: IBD patients with IBS symptoms in remission

Key Statistics

5

الدراسات

800

المشاركون

Positive

B

التقييم

Referenced Papers

Beneficial microbes 2021 69 اقتباسات
Central-European journal of … 2020 38 اقتباسات
Foods (Basel, Switzerland) 2019 21 اقتباسات
PloS one 2012 445 اقتباسات
Polski merkuriusz lekarski … 2012 8 اقتباسات
Zeitschrift fur Gastroenterologie 2005 17 اقتباسات
Journal of clinical … 2004 205 اقتباسات
Current treatment options … 2002 5 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:
10-20 billion CFU/day
ibssupport:
10 billion CFU/day (299v strain) for 4 weeks minimum

الحد الأعلى: Well-tolerated up to 20 billion CFU/day in clinical trials

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
None -- Positive 3154
None -- Positive --
Bifidobacterium animalis subsp. lactis BB-12 and Lactiplantibacillus plantarum ATCC 14917 4 weeks Positive 25
None 8 weeks Positive 1098
1e9 CFU/day + GOS 10 g/L -- Positive --
None 12 weeks Neutral 61
None -- Positive --
None -- Positive --

أفضل وقت للتناول: On an empty stomach or before meals

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Mild gas and bloating during initial use
  • Occasional loose stools
  • Histamine-related symptoms in sensitive individuals (histamine-producing species)
  • Very rare: bacteremia in immunocompromised individuals

التفاعلات المعروفة

  • Antibiotics (may reduce probiotic viability; space dosing 2 hours apart)
  • Immunosuppressants (theoretical risk in immunocompromised patients)
  • Histamine-intolerance medications (L. plantarum may produce biogenic amines)

الحد الأقصى المسموح به: Well-tolerated up to 20 billion CFU/day in clinical trials

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Lactobacillus plantarum help with Irritable Bowel Syndrome (IBS)?
Based on 5 studies with 800 participants, there is moderate evidence from clinical studies that Lactobacillus plantarum may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is B (Good Evidence).
How much Lactobacillus plantarum should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 10-20 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Lactobacillus plantarum?
Reported side effects may include Mild gas and bloating during initial use, Occasional loose stools, Histamine-related symptoms in sensitive individuals (histamine-producing species), Very rare: bacteremia in immunocompromised individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Lactobacillus plantarum and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 5 peer-reviewed studies with 800 total participants. The overall direction of effect is positive.

Related Evidence

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.